166 related articles for article (PubMed ID: 10620443)
1. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix.
Burnett AF; Roman LD; Garcia AA; Muderspach LI; Brader KR; Morrow CP
Gynecol Oncol; 2000 Jan; 76(1):63-6. PubMed ID: 10620443
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
Look KY; Blessing JA; Levenback C; Kohler M; Chafe W; Roman LD
Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Brewer CA; Blessing JA; Nagourney RA; McMeekin DS; Lele S; Zweizig SL
Gynecol Oncol; 2006 Feb; 100(2):385-8. PubMed ID: 16271750
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.
Schilder RJ; Blessing JA; Morgan M; Mangan CE; Rader JS
Gynecol Oncol; 2000 Feb; 76(2):204-7. PubMed ID: 10637071
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer.
Matulonis UA; Campos S; Duska L; Krasner CN; Atkinson T; Penson RT; Seiden MV; Verrill C; Fuller AF; Goodman A;
Gynecol Oncol; 2006 Oct; 103(1):160-4. PubMed ID: 16566993
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
8. Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.
Umanzor J; Aguiluz M; Pineda C; Andrade S; Erazo M; Flores C; Santillana S
Gynecol Oncol; 2006 Jan; 100(1):70-5. PubMed ID: 16288803
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix.
Morris M; Gershenson DM; Burke TW; Mitchell MF; Levenback C; Atkinson N; Wharton JT
Gynecol Oncol; 1994 May; 53(2):234-8. PubMed ID: 8188085
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2.
Termrungruanglert W; Tresukosol D; Vasuratna A; Sittisomwong T; Lertkhachonsuk R; Sirisabya N
Gynecol Oncol; 2005 May; 97(2):576-81. PubMed ID: 15863162
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Gershenson DM; McGehee R
J Clin Oncol; 1999 Sep; 17(9):2676-80. PubMed ID: 10561341
[TBL] [Abstract][Full Text] [Related]
12. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix.
Errihani H; M'rabti H; Ismaili N; Inrhaoun H; Elghissassi I
Int J Gynecol Cancer; 2011 Feb; 21(2):373-7. PubMed ID: 21270619
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix.
Pohlmann P; DiLeone LP; Cancella AI; Caldas AP; Dal Lago L; Campos O; Monego E; Rivoire W; Schwartsmann G
Am J Clin Oncol; 2002 Oct; 25(5):496-501. PubMed ID: 12393992
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma.
Dueñas-Gonzalez A; Lopez-Graniel C; Gonzalez A; Reyes M; Mota A; Muñoz D; Solorza G; Hinojosa LM; Guadarrama R; Florentino R; Mohar A; Meléndez J; Maldonado V; Chanona J; Robles E; De la Garza J
Ann Oncol; 2001 Apr; 12(4):541-7. PubMed ID: 11398890
[TBL] [Abstract][Full Text] [Related]
16. Weekly cisplatin/low-dose gemcitabine combination for advanced and recurrent cervical carcinoma.
Dueñas-Gonzalez A; Hinojosa-García LM; López-Graniel C; Meléndez-Zagla J; Maldonado V; de la Guerra J
Am J Clin Oncol; 2001 Apr; 24(2):201-3. PubMed ID: 11334051
[TBL] [Abstract][Full Text] [Related]
17. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma.
Zarbá JJ; Jaremtchuk AV; Gonzalez Jazey P; Keropian M; Castagnino R; Mina C; Arroyo G;
Ann Oncol; 2003 Aug; 14(8):1285-90. PubMed ID: 12881394
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck.
Specht L; Larsen SK; Hansen HS
Ann Oncol; 2000 Jul; 11(7):845-9. PubMed ID: 10997812
[TBL] [Abstract][Full Text] [Related]
19. Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.
Ngan RK; Yiu HH; Lau WH; Yau S; Cheung FY; Chan TM; Kwok CH; Chiu CY; Au SK; Foo W; Law CK; Tse KC
Ann Oncol; 2002 Aug; 13(8):1252-8. PubMed ID: 12181249
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
